Our prospective radiomics study demonstrates that ultrafast MRI exhibits superior classification performance for breast cancer HER2 status and molecular subtype compared to standard MRI for radiologists of different experience levels (a dedicated breast radiologist and a radiology resident). This evidence concerns the gene ERBB2 and breast carcinoma.